Diagnosis becomes more complex when overlapping autoimmune diseases such as Crohn’s disease are present, especially in patients receiving immunosuppressive or biologic agents such as anti-tumor necrosis factor-alpha (TNF-α) therapies. This evidence concerns the gene TNF and autoimmune disease.